Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process (Q45420827)

14 December 2017

title

Genetic stability of live, cold-adapted influenza virus components of the FluMist/CAIV-T vaccine throughout the manufacturing process (English)

1 reference

14 December 2017

Deborah A Buonagurio

1

1 reference

14 December 2017

Thomas M Bechert

2

1 reference

14 December 2017

Chin-Fen Yang

3

1 reference

14 December 2017

Leonid Shutyak

4

1 reference

14 December 2017

Gail A D'Arco

5

1 reference

14 December 2017

Yuriy Kazachkov

6

1 reference

14 December 2017

Hai-Ping Wang

7

1 reference

14 December 2017

Eduardo A Rojas

8

1 reference

14 December 2017

Robert E O'Neill

9

1 reference

14 December 2017

Richard R Spaete

10

1 reference

14 December 2017

Kathleen L Coelingh

11

1 reference

14 December 2017

Timothy J Zamb

12

1 reference

14 December 2017

Mohinder S Sidhu

13

1 reference

14 December 2017

Stephen A Udem

14

1 reference

14 December 2017

language of work or name

English

0 references

publication date

21 November 2005

1 reference

14 December 2017

1 reference

14 December 2017

volume

24

1 reference

14 December 2017

issue

12

1 reference

14 December 2017

page(s)

2151-2160

1 reference

The global impact of influenza on morbidity and mortality

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

The socio-economic burden of influenza

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

The development of live attenuated cold-adapted influenza virus vaccine for humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Sequence comparison of wild-type and cold-adapted B/Ann Arbor/1/66 influenza virus genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Sequence comparisons of A/AA/6/60 influenza viruses: mutations which may contribute to attenuation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Multiple gene segments control the temperature sensitivity and attenuation phenotypes of ca B/Ann Arbor/1/66.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

The mutation rate and variability of eukaryotic viruses: an analytical review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Canine distemper virus L gene: sequence and comparison with related viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Multiple amino acid residues confer temperature sensitivity to human influenza virus vaccine strains (FluMist) derived from cold-adapted A/Ann Arbor/6/60.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Structural identification of the antibody-binding sites of Hong Kong influenza haemagglutinin and their involvement in antigenic variation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Estimating efficacy of trivalent, cold-adapted, influenza virus vaccine (CAIV-T) against influenza A (H1N1) and B using surveillance cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Effects of host-dependent glycosylation of hemagglutinin on receptor-binding properties on H1N1 human influenza A virus grown in MDCK cells and in embryonated eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Evidence for host-cell selection of influenza virus antigenic variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Alterations in the hemagglutinin associated with adaptation of influenza B virus to growth in eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.11.007

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VACCINE.2005.11.007

1 reference

14 December 2017

1 reference